1 / 13

Veterinary Diagnostics Market Trends, Size, Share & Analysis 2019-2017-Inkwood Research

The global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.Know more @ https://www.inkwoodresearch.com/reports/north-america-veterinary-diagnostics-market/

inkwoodresearch
Télécharger la présentation

Veterinary Diagnostics Market Trends, Size, Share & Analysis 2019-2017-Inkwood Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VETERINARY DIAGNOSTICS MARKET FORECAST2019-2027

  2. The diagnosis, treatment and prevention of diseases or other conditions in animals falls under the category of veterinary diagnostic services. • The aim is to detect the underlying pathogenesis responsible for the disease/disorder associated with the companion animals and livestock, increase the production of livestock products effectively saving the budget, and to keep a check on both the domestic animals & wildlife to human transmission of various diseases. • The global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.

  3. Veterinary diagnostics have incorporated technologies and methods gained from human diagnostics and mainstream healthcare services to develop a fully-fledged co-dependent market that remains open to further innovation. • The market is primarily driven by increasing veterinary care expenditures and the introduction of novel veterinary diagnostic instruments. • The technology and product of the veterinary diagnostic market are used extensively for many purposes. Microfluidics, miniaturization and information technology (IT) features are supporting the development and widespread commercialization of point-of-care (POC) and decentralized IVD devices used outside of the traditional clinical laboratory environment. • This has resulted in the progress of companion animal care as POC and granted permits to the veterinarians to carry out accurate in-clinic testing, subsequently shortening the time to results and allowing direct billing for additional revenue.

  4. “The global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. ”

  5. Technological advancements for a specific diagnosis for animal diseases are responsible for propelling the market at 7.34% CAGR during the forecasting years of 2019-2027.

  6. The European veterinary diagnostic market has been predicted to rise its CAGR by 7.65% during the tenure of 2019-2027.

  7. The veterinary diagnostic market of the Asia Pacific region is predicted to grow at a CAGR of 8.38% during the forecasting years of 2019-2027.

  8. The extensiveness of the product portfolio, research and development expenditure and the geographical presence of the companies established and contributing to the global veterinary diagnostic market have been progressive by leaps. Some of these companies operating in the global economy are Thermo Fisher Scientific Inc., Zoetis Inc., Bio-Rad Laboratories, Inc., Horiba, Ltd., Biomedica, ID Vet, Alvedia, Heska Corporation, Qiagen N.V., Neogen Corporation, Fujifilm Europe GmbH, Idexx Laboratories, Inc., Acon Laboratories, Inc., Sysmex Corporation and Henry Schein, Inc. (U.S.).

More Related